Skip to content
Maitreya Medicare logo

Maitreya Medicare

MAITREYA NSE
₹120.20 No trade today
P/E
19.39
View as Markdown
MCP
Close 4 Nov 2026 ₹120.20 −110.70 −47.9% 1Y
Start ₹230.90

Key Fundamentals

SMEHealthcare ServicesHealthcare

Price-based figures as of · TTM

ROCE
−1.85%
Debt to Equity
1.15
EPS (TTM)
₹6.20
Book Value
₹35.79
Market Cap
—
P/E (TTM)
19.39
P/B
3.36
ROE
−9.34%
Dividend Yield
0.00%
EBITDA
₹70.00 L
52W High
₹292.95
52W Low
₹103.10
Volume
0

Peer Comparison

Healthcare › Healthcare Services › Hospitals › Hospital

Maitreya Medicare peer comparison
Apollo Hospitals
₹8,599.5059.18₹1,22,850 Cr13.040.24%21.20%17.40%₹26,430 Cr₹2,171 Cr
Max Healthcare Institute
₹927.1561.89₹89,301 Cr7.960.22%14.70%14.70%₹8,712 Cr₹1,457 Cr
Manipal Health Enterprises
₹667.2088.96₹86,479 Cr5.340.00%6.64%8.30%₹11,400 Cr₹906 Cr
Aster DM Healthcare
₹719.55117.00₹59,927 Cr14.910.44%11.30%11.60%₹4,876 Cr₹363 Cr
Fortis Healthcare
₹790.6556.96₹59,706 Cr6.030.13%11.20%13.40%₹9,506 Cr₹1,070 Cr
Narayana Hrudayalaya
₹1,931.5048.36₹39,090 Cr7.890.24%20.50%15.50%₹9,072 Cr₹816 Cr
Global Health
₹1,402.0067.76₹37,618 Cr9.520.04%15.20%17.40%₹4,683 Cr₹552 Cr
Maitreya Medicare (this company)
₹120.2019.39₹86 Cr3.360.00%−9.34%−1.85%₹49 Cr₹3 Cr
Median 8 companies₹858.9060.54₹59,817 Cr7.930.18%13.00%14.05%₹8,892 Cr₹861 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

37 Weak

Data confidence 100/100

surveillance:ASM1

Category scores

Quality
55
Good
Returns, margins, earnings quality 22% weight
Valuation
34
Poor
Cheap vs sector & own history 24% weight
Growth
28
Poor
Sales & profit trajectory 9% weight
Financial Health
33
Poor
Solvency, leverage, coverage 9% weight
Momentum
15
Poor
Trend strength, vol-adjusted 12% weight
Ownership
50
Average
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

No strengths listed

Weaknesses

5
  • Stock is trading at 3.27 times its book value
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -5.59% over past five years.
  • Company has a low return on equity of 3.44% over last 3 years.
  • Company might be capitalizing the interest cost

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bearish1144
OscillatorsBullish243
Moving AveragesStrong Bearish901

Key readings

RSI (14)
46.17
Neutral
MACD (12,26,9)
2.11
Bearish
SMA (50)
119.91
Bullish
SMA (200)
162.97
Bearish

As of

Growth Rate

From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.

Revenue

Revenue growth by window
5Y−5.59%
3Y+2.22%
1Y−6.71%

Net profit

Net profit growth by window
5YTurned to loss
3YTurned to loss
1YTurned to loss

Operating cash flow

Operating cash flow growth by window
5Y+12.61%
3Y+46.00%
1Y+59.29%

Operating margin· change in pp

Operating margin growth by window
5Y−13.67 pp
3Y−19.19 pp
1Y−11.56 pp

Trailing twelve months: Results are not reported for each of the last eight quarters, so there is no trailing-twelve-month figure.

Revenue by year

Revenue by year, ₹ crore
Mar 2021₹55.93 Cr
Mar 2022₹49.35 Cr
Mar 2023₹39.28 Cr
Mar 2024₹46.08 Cr
Mar 2025₹44.98 Cr
Mar 2026₹41.96 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2021₹4.24 Cr
Mar 2022₹1.14 Cr
Mar 2023₹4.25 Cr
Mar 2024₹2.97 Cr
Mar 2025₹1.82 Cr
Mar 2026−₹2.47 Cr

Half-yearly Results

₹ Cr
MAITREYA half-yearly results, ₹ crore
Particulars Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Sales
24.79
23.01
24.36
22.3
23.7
21.15
Expenses
20.23
21.85
21.18
20.6
22.66
22.64
Operating Profit
4.56
1.16
3.18
1.7
1.04
−1.49
OPM %
18.39%
5.04%
13.05%
7.62%
4.39%
−7.04%
Other Income
0.05
0.22
0.19
0.38
0.23
0.76
Interest
0.39
0.46
0.45
0.35
0.43
1.06
Depreciation
0.64
0.64
0.66
0.84
0.79
0.73
PBT
3.58
0.28
2.26
0.89
0.05
−2.52
Tax %
28.49%
67.86%
26.11%
83.15%
160%
−3.97%
Net Profit
2.56
0.09
1.67
0.15
−0.04
−2.43
EPS (₹)
5.16
0.13
2.46
0.22
−0.06
−3.59

Profit & Loss

₹ Cr
MAITREYA profit and loss, annual, ₹ crore
Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
55.93
49.35
39.28
46.08
44.98
41.96
Expenses
48.68
45.98
32.02
40.08
40.1
42.26
Operating Profit
7.25
3.37
7.26
6
4.88
−0.3
OPM %
12.96%
6.83%
18.48%
13.02%
10.85%
−0.71%
Other Income
0.43
0.33
0.53
0.3
0.57
0.89
Interest
0.82
0.78
0.57
0.84
0.8
1.48
Depreciation
1.09
1.32
1.29
1.27
1.5
1.52
PBT
5.77
1.6
5.93
4.19
3.15
−2.41
Tax %
26.52%
28.75%
28.16%
29.12%
42.54%
2.49%
Net Profit
4.24
1.14
4.25
2.97
1.82
−2.47
EPS (₹)
4,240
1,140
8.57
4.38
2.69
−3.65
Div. Payout %
0%
0%
0%
0%
0%
0%

Balance Sheet

₹ Cr
MAITREYA balance sheet, annual, ₹ crore
Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
0.01
0.01
4.96
6.78
6.78
6.78
Reserves
3.85
4.7
3.81
18.07
19.94
17.48
Borrowings
14.24
12.38
11.59
11.1
10.53
27.9
Other Liabilities
7.17
7.4
8.55
7.91
10.75
16.28
Total Liabilities
25.27
24.49
28.91
43.86
48
68.44
Fixed Assets
13.84
13.4
11.6
14.32
15.26
40.81
CWIP
0
0
0
0
0
0
Investments
1.07
0.32
0.68
1.47
0.04
0.05
Other Assets
10.36
10.77
16.63
28.07
32.7
27.58
Total Assets
25.27
24.49
28.91
43.86
48
68.44

Cash Flow

₹ Cr
MAITREYA cash flow, annual, ₹ crore
Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
4.45
0.08
2.59
−2.5
5.06
8.06
Investing
−5.07
−0.02
0.36
−5.44
−7.37
−26.74
Financing
2.16
−1.86
−1.59
12.21
3.67
19.04
Net Cash Flow
1.55
−1.8
1.36
4.27
1.36
0.36
Free Cash Flow
−1.17
−0.82
3.16
−4.11
2.68
−19.02
CFO/OP
77
54
40
−12
134
−2,727

Ratios

MAITREYA financial ratios, annual
Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
31.91
43.42
90.41
109
121
95.86
Inventory Days
68.78
40.82
69.86
40.26
36.56
63.48
Days Payable
258
222
320
207
200
303
Cash Conversion Cycle
−157
−138
−159
−58.47
−41.58
−144
Working Capital Days
−4.11
3.11
43.12
73.43
73.68
−11.05
ROCE %
—
12.33%
32.85%
17.3%
10.6%
−1.85%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Maitreya Medicare insights

58 extracted metrics across FY21–FY26.

Shareholding Pattern

As of Sep 2026

  • Promoters 73.11%
  • Public 21.49%
  • Others 5.40%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Documents

Frequently Asked Questions about Maitreya Medicare

What does Maitreya Medicare Ltd do?
Incorporated in 2019, Maitreya Medicare Ltd is an integrated multispeciality hospital with primary secondary & tertiary care situated in Surat, Gujrat.
Where is Maitreya Medicare Ltd (MAITREYA) listed?
Maitreya Medicare Ltd trades as MAITREYA on the NSE.
Which sector does Maitreya Medicare Ltd belong to?
Maitreya Medicare Ltd is classified under the Healthcare Services sector, in the Hospitals industry.
What is the PE ratio of Maitreya Medicare Ltd?
Maitreya Medicare Ltd trades at a PE ratio of 19.39 as of 4 Nov 2026, on earnings per share of ₹6.2, against a book value of ₹35.79 per share.
What is the 52-week high and low of Maitreya Medicare Ltd?
Over the last 52 weeks Maitreya Medicare Ltd has traded between ₹103.1 and ₹292.95 as of 4 Nov 2026.
What is the Return on Equity (ROE) of Maitreya Medicare Ltd?
Maitreya Medicare Ltd reported a return on equity of -9.34%. Its debt-to-equity ratio is 1.15.

Company Information

Incorporated in 2019, Maitreya Medicare Ltd is an integrated multispeciality hospital with primary secondary & tertiary care situated in Surat, Gujrat.

Website maitreyahospitals.com
Listed 7 Nov 2023
Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/MAITREYA.md for Maitreya Medicare Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Hospital & Healthcare Services stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month